Versant Venture Management, LLC - APREA THERAPEUTICS INC ownership

APREA THERAPEUTICS INC's ticker is APRE and the CUSIP is 03836J102. A total of 64 filers reported holding APREA THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.6%.

Quarter-by-quarter ownership
Versant Venture Management, LLC ownership history of APREA THERAPEUTICS INC
ValueSharesWeighting
Q3 2021$6,437,000
+4.7%
1,259,6620.0%2.66%
+30.8%
Q2 2021$6,147,000
-4.3%
1,259,6620.0%2.04%
+62.7%
Q1 2021$6,424,000
-8.5%
1,259,662
-11.7%
1.25%
+71.7%
Q4 2020$7,018,000
-84.3%
1,426,328
-23.1%
0.73%
-91.1%
Q3 2020$44,613,000
-99.9%
1,854,2290.0%8.16%
-21.0%
Q2 2020$71,907,001,0001,854,22910.33%
Other shareholders
APREA THERAPEUTICS INC shareholders Q2 2020
NameSharesValueWeighting ↓
5AM Venture Management, LLC 1,377,654$6,778,0002.28%
Versant Venture Management, LLC 1,426,328$7,018,0000.73%
COASTAL INVESTMENT MANAGEMENT, L.P. 41,965$206,0000.38%
Redmile Group, LLC 1,268,718$6,242,0000.08%
Gyon Technologies Capital Management, LP 41,801$206,0000.07%
SECTORAL ASSET MANAGEMENT INC 163,681$805,0000.06%
Palo Alto Investors LP 128,770$634,0000.03%
Walleye Capital LLC 100,800$496,0000.03%
Virtus ETF Advisers LLC 10,261$50,0000.02%
Candriam S.C.A. 362,346$1,783,0000.01%
View complete list of APREA THERAPEUTICS INC shareholders